CRP and depressive symptom measurement: In RA patients, CRP is a reliable marker of systemic inflammation, and its levels appear to be related with the risk of associated comorbidities, like cardiovascular diseases, diabetes, metabolic syndrome, pulmonary diseases, and depression [21].